Goldman Sachs Group Inc Myriad Genetics Inc Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

A detailed history of Goldman Sachs Group Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 913,881 shares of MYGN stock, worth $14 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
913,881
Previous 877,874 4.1%
Holding current value
$14 Million
Previous $21.5 Million 16.49%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$23.97 - $28.6 $863,087 - $1.03 Million
36,007 Added 4.1%
913,881 $25 Million
Q2 2024

Aug 13, 2024
SELL
$17.98 - $25.47 $535,516 - $758,598
-29,784 Reduced 3.28%
877,874 $21.5 Million
Q1 2024

May 15, 2024
SELL
$17.59 - $23.59 $3.17 Million - $4.25 Million
-180,331 Reduced 16.57%
907,658 $19.4 Million
Q4 2023

Feb 13, 2024
SELL
$13.91 - $21.32 $1.43 Million - $2.2 Million
-103,032 Reduced 8.65%
1,087,989 $20.8 Million
Q3 2023

May 14, 2024
BUY
$15.99 - $23.22 $1.65 Million - $2.39 Million
103,032 Added 9.47%
1,191,021 $19.1 Million
Q3 2023

Nov 14, 2023
BUY
$15.99 - $23.22 $263,211 - $382,224
16,461 Added 1.4%
1,191,021 $19.1 Million
Q2 2023

May 14, 2024
SELL
$17.56 - $23.76 $3.65 Million - $4.94 Million
-208,047 Reduced 15.05%
1,174,560 $27.2 Million
Q2 2023

Aug 14, 2023
SELL
$17.56 - $23.76 $3.65 Million - $4.94 Million
-208,047 Reduced 15.05%
1,174,560 $27.2 Million
Q1 2023

May 14, 2024
SELL
$15.26 - $23.75 $140,529 - $218,713
-9,209 Reduced 0.66%
1,382,607 $32.1 Million
Q1 2023

May 11, 2023
SELL
$15.26 - $23.75 $140,529 - $218,713
-9,209 Reduced 0.66%
1,382,607 $32.1 Million
Q4 2022

May 14, 2024
SELL
$14.51 - $20.99 $3.34 Million - $4.84 Million
-230,505 Reduced 14.21%
1,391,816 $20.2 Million
Q4 2022

Feb 13, 2023
SELL
$14.51 - $20.99 $3.34 Million - $4.84 Million
-230,505 Reduced 14.21%
1,391,816 $20.2 Million
Q3 2022

May 14, 2024
BUY
$18.21 - $27.88 $5.84 Million - $8.94 Million
320,540 Added 24.62%
1,622,321 $31 Million
Q3 2022

Nov 10, 2022
BUY
$18.21 - $27.88 $5.84 Million - $8.94 Million
320,540 Added 24.62%
1,622,321 $31 Million
Q2 2022

May 14, 2024
BUY
$16.45 - $25.88 $3.52 Million - $5.53 Million
213,792 Added 19.65%
1,301,781 $23.7 Million
Q2 2022

Aug 15, 2022
SELL
$16.45 - $25.88 $4.45 Million - $7 Million
-270,660 Reduced 17.21%
1,301,781 $23.7 Million
Q1 2022

May 16, 2022
SELL
$22.67 - $28.01 $6.28 Million - $7.75 Million
-276,820 Reduced 14.97%
1,572,441 $39.6 Million
Q4 2021

Feb 14, 2022
SELL
$24.13 - $32.63 $6.8 Million - $9.19 Million
-281,779 Reduced 13.22%
1,849,261 $51 Million
Q3 2021

Nov 10, 2021
BUY
$29.97 - $36.66 $63.9 Million - $78.1 Million
2,131,040 New
2,131,040 $68.8 Million

Others Institutions Holding MYGN

# of Institutions
253
Shares Held
90.9M
Call Options Held
100K
Put Options Held
34K
View Full List

About MYRIAD GENETICS INC

MYGN Quotes by TradingView
  • Ticker MYGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 80,634,800
  • Market Cap $1.23B
  • Description
  • Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...
More about MYGN
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email